These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 25831424)
1. Preparation and evaluation of luteolin-phospholipid complex as an effective drug delivery tool against GalN/LPS induced liver damage. Khan J; Saraf S; Saraf S Pharm Dev Technol; 2016; 21(4):475-86. PubMed ID: 25831424 [TBL] [Abstract][Full Text] [Related]
3. Development of quercetin-phospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in SD rats. Zhang K; Zhang M; Liu Z; Zhang Y; Gu L; Hu G; Chen X; Jia J Fitoterapia; 2016 Sep; 113():102-9. PubMed ID: 27431774 [TBL] [Abstract][Full Text] [Related]
4. Enhanced bioavailability and hepatoprotectivity of optimized ursolic acid-phospholipid complex. Biswas S; Mukherjee PK; Harwansh RK; Bannerjee S; Bhattacharjee P Drug Dev Ind Pharm; 2019 Jun; 45(6):946-958. PubMed ID: 30767678 [TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882 [TBL] [Abstract][Full Text] [Related]
6. Hepatoprotective effect of 3-alkynyl selenophene on acute liver injury induced by D-galactosamine and lipopolysaccharide. Wilhelm EA; Jesse CR; Roman SS; Nogueira CW; Savegnago L Exp Mol Pathol; 2009 Aug; 87(1):20-6. PubMed ID: 19344711 [TBL] [Abstract][Full Text] [Related]
7. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis. Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589 [TBL] [Abstract][Full Text] [Related]
8. A phospholipid complex to improve the oral bioavailability of flavonoids. Wang H; Cui Y; Fu Q; Deng B; Li G; Yang J; Wu T; Xie Y Drug Dev Ind Pharm; 2015; 41(10):1693-703. PubMed ID: 25496311 [TBL] [Abstract][Full Text] [Related]
9. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid. Dora CP; Kushwah V; Katiyar SS; Kumar P; Pillay V; Suresh S; Jain S Int J Pharm; 2017 Dec; 534(1-2):1-13. PubMed ID: 28970115 [TBL] [Abstract][Full Text] [Related]
10. Phytophospholipid Complex of Caffeic Acid: Development, In vitro Characterization, and In Vivo Investigation of Antihyperlipidemic and Hepatoprotective Action in Rats. Mangrulkar S; Shah P; Navnage S; Mazumdar P; Chaple D AAPS PharmSciTech; 2021 Jan; 22(1):28. PubMed ID: 33404939 [TBL] [Abstract][Full Text] [Related]
11. Hepatoprotective effect of Commiphora myrrha against d-GalN/LPS-induced hepatic injury in a rat model through attenuation of pro inflammatory cytokines and related genes. Ahmad A; Raish M; Ganaie MA; Ahmad SR; Mohsin K; Al-Jenoobi FI; Al-Mohizea AM; Alkharfy KM Pharm Biol; 2015; 53(12):1759-67. PubMed ID: 25864920 [TBL] [Abstract][Full Text] [Related]
12. Selective blockade of mGlu5 metabotropic glutamate receptors is hepatoprotective against fulminant hepatic failure induced by lipopolysaccharide and D-galactosamine in mice. Jesse CR; Wilhelm EA; Bortolatto CF; Savegnago L; Nogueira CW J Appl Toxicol; 2009 May; 29(4):323-9. PubMed ID: 19153979 [TBL] [Abstract][Full Text] [Related]
13. Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects. Onoue S; Nakamura T; Uchida A; Ogawa K; Yuminoki K; Hashimoto N; Hiza A; Tsukaguchi Y; Asakawa T; Kan T; Yamada S Eur J Pharm Sci; 2013 Jul; 49(4):453-60. PubMed ID: 23707470 [TBL] [Abstract][Full Text] [Related]
14. Hepatoprotective effect of germanium-containing Spirulina in rats with (D)-galactosamine- and lipopolysaccharide-induced hepatitis. Yoshinari O; Shiojima Y; Igarashi K Br J Nutr; 2014 Jan; 111(1):135-40. PubMed ID: 23768655 [TBL] [Abstract][Full Text] [Related]
15. Preparation of a nanoscale dihydromyricetin-phospholipid complex to improve the bioavailability: in vitro and in vivo evaluations. Zhao X; Shi C; Zhou X; Lin T; Gong Y; Yin M; Fan L; Wang W; Fang J Eur J Pharm Sci; 2019 Oct; 138():104994. PubMed ID: 31302210 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of forsythiaside A on lipopolysaccharide/d-galactosamine-induced liver injury. Pan CW; Zhou GY; Chen WL; Zhuge L; Jin LX; Zheng Y; Lin W; Pan ZZ Int Immunopharmacol; 2015 May; 26(1):80-5. PubMed ID: 25797347 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of luteolin against apoptotic liver damage induced by D-galactosamine/lipopolysaccharide in mice. Lee WC; Jung HA; Choi JS; Kim YS; Lee SM J Nat Prod; 2011 Sep; 74(9):1916-21. PubMed ID: 21899269 [TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization, and bioavailability of ursodeoxycholic acid-phospholipid complex in vivo. Yue PF; Yuan HL; Xie H; Xiao XH; Yang M; Liao MX; Zhu WF; Cai PL Drug Dev Ind Pharm; 2008 Jul; 34(7):708-18. PubMed ID: 18612911 [TBL] [Abstract][Full Text] [Related]
19. Phytochylomicron as a dual nanocarrier for liver cancer targeting of luteolin: in vitro appraisal and pharmacodynamics. Elnaggar YS; Elsheikh MA; Abdallah OY Nanomedicine (Lond); 2018 Jan; 13(2):209-232. PubMed ID: 29199881 [TBL] [Abstract][Full Text] [Related]
20. Novel rifampicin-phospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation. Singh C; Bhatt TD; Gill MS; Suresh S Int J Pharm; 2014 Jan; 460(1-2):220-7. PubMed ID: 24188983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]